| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.087 | 0.9 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |